Please login to the form below

Not currently logged in
Email:
Password:

skin cancer

This page shows the latest skin cancer news and features for those working in and with pharma, biotech and healthcare.

ICR research shows how skin cancer cells invade new tissues

ICR research shows how skin cancer cells invade new tissues

Targeting a specific gene could lead to treatments that prevent cancer from spreading. ... Melanoma skin cancer cells harness a gene – usually used to create connections between nerves – to escape from their immediate area and invade new tissues,

Latest news

More from news
Approximately 23 fully matching, plus 137 partially matching documents found.

Latest Intelligence

  • Encouraging signs in biomarker R&D Encouraging signs in biomarker R&D

    For example, skin cancer patients who carry a BRAF V600 mutation are more likely to respond to BRAF inhibitors like Roche’s Zelboraf (Vemurafenib) than people without such mutations. ... He also cited an FDA-approved TMB test developed by Foundation

  • Digital health Digital health

    What digital health has delivered to date is amazing. The examples are legion: an application which can differentially diagnose lesions on skin with 20-30 times more accuracy than a doctor ... when it comes to skin cancer, or HealthTap’s Dr AI which

  • Case study: Skin cancer awareness

    Skin cancer is on the increase. It is one of the most common cancers in the 15-24 age group and a significant cause of death. ... Posters and leaflets do not get through to younger people; at this age they feel invincible and believe skin cancer will

More from intelligence
Approximately 0 fully matching, plus 3 partially matching documents found.

Latest appointments

  • CytomX appoints Rachel Humphrey chief medical officer CytomX appoints Rachel Humphrey chief medical officer

    Before her time at AZ and Eli Lilly, Humphrey was also VP of product development at Bristol-Myers Squibb where she led all aspects of clinical development of the skin-cancer

  • Kite Pharma appoints Zelboraf scientist as CMO Kite Pharma appoints Zelboraf scientist as CMO

    Keith Nolop joins US cancer biotech from Plexxikon. Dr Keith Nolop, one of the chief scientists behind the development of Roche's personalised skin cancer drug Zelboraf, has been appointed chief ... At Plexxikon, he also led the filing of eight

More from appointments
Approximately 0 fully matching, plus 2 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 2 fully matching, plus 7 partially matching documents found.

Subscribe to our email news alerts

Featured jobs

PMHub

Add my company
Cuttsy + Cuttsy

How do you understand what patients really need, without actually living their lives? How do you walk in someone else’s...

Latest intelligence

The communication challenge of helping he next generation to be healthier
As the pressure on the health service increases the health of the next generation is vital for everyone. How do we show positive attitudes and change behaviour while future proofing...
Are we losing sight of what the democratisation of healthcare really looks like?
We have a core responsibility as healthcare communicators to consistently drive for better inclusion, engagement and compliance. What does the ‘democratisation of healthcare’ really look like?...
William Kilgallon
How the Royal Society’s EiR programme can help to drive UK innovation
...